Pristyn Care's Financial Leap: Revolutionizing Secondary Care Surgeries

Pristyn Care, a top healthcare provider in India, reported strong financial results for 2023-24, with a 28% revenue increase and significant cost reductions. The company's focus on secondary care surgeries has led to improved operational efficiency and patient growth. Continued success is expected in 2024-25.

Pristyn Care, a leading name in India's healthcare sector, has unveiled its financial results for the fiscal year 2023-24. Reporting an impressive 28% rise in revenue to ₹632 crore, the healthcare provider has effectively cut down operational costs, particularly in its secondary care surgical segment.

During this period, the company witnessed a remarkable 42% reduction in EBITDA burn, signaling enhanced efficiency driven by an increase in organic patient traffic from under 40% to nearly 60%. This shift allowed for a substantial decrease in marketing expenses, fueling further EBITDA growth.

Pristyn Care forecasts a 35% revenue surge for 2024-25 and projects a continued reduction in EBITDA burn by over 60%. The organization's strategic investments in advanced medical technology and strengthened insurance partnerships have positioned it as a market leader in high-value surgeries, aiming for profitability by 2026 and an IPO by 2028.

(With inputs from agencies.)